Immunology

This meeting examines how pollutants, infections and other environmental exposures interact with genetic susceptibility to cause chronic inflammatory disease. Immunologists and environmental scientists study how barrier-surface immunity decodes these influences. The programme combines early-life and population cohorts, single-cell methods, microbial and dietary environments, experimental exposures and mucosal defence to connect mechanisms with prevention and treatment. Programme participants include Martine Vrijheid (Barcelona Institute for Global Health, Spain); Petter Brodin (Imperial College London, UK); Darragh Duffy (Pasteur Institute, France); Magnus Rattray (University of Manchester, UK); Sheena Cruickshank (University of Manchester, UK); Fenna Sillé (Johns Hopkins University, US). Schedule: 12–13 October 2026, 09:00–17:00 each day, Europe/London (BST, UTC+1). Researchers may attend online or at the Royal Society, 6–9 Carlton House Terrace, London SW1Y 5AG, United Kingdom. Both modes are free; advance registration is required using the appropriate online or in-person ticket. Optional lunch is £25/day, subject to availability; outside food is permitted. A poster session is planned for 12 October; no fixed submission deadline is stated.

Ilaria Ferlenghi discusses a career spanning structural biology, cryo-electron microscopy, vaccine research and development, and the growing role of artificial intelligence and machine learning in scientific innovation and entrepreneurship.

The webinar compares prefusion stabilization of vaccine antigens with epitope scaffolding on non-antigen protein backbones. It examines the advantages and limitations of each computational, structure-based vaccine design strategy.

This EMBO | EMBL Symposium brings cancer researchers together to examine how tumours spread and resist treatment. Topics include circulating and metastasis-initiating cells, invasion, epigenetic regulation, dormancy, cellular plasticity, immune escape and the tumour microenvironment. The programme connects biological mechanisms with imaging, single-cell and spatial profiling, computational analysis and disease models. The event runs from 10 to 13 November 2026 at the EMBL Advanced Training Centre in Heidelberg, with virtual participation available. Abstract submissions are closed. On-site registration closes on 29 September; virtual registration remains available until 3 November. Registration fees and the two booking routes are listed on the organizer page.

A one-year research assistant appointment in the Helleday Laboratory at SciLifeLab connects AI-driven peptide design with translational cancer research. The work supports experimental research and evaluates therapeutic targets for disease relevance, selectivity, safety and prospects for clinical translation. Applicants should combine practical molecular and cellular biology with experience interpreting biological data. Applications are submitted through Karolinska’s recruitment portal by 5 October 2026.

Marcus Buggert’s group at the Centre for Infectious Medicine develops mRNA-based, CD19-directed CAR T cells for chronic lymphocytic leukaemia. The project uses electroporation and targeted lipid nanoparticles to generate transient CAR expression and examines how disease stage, treatment and T-cell differentiation affect killing of malignant B cells. Work combines primary human cells and patient samples, functional co-cultures, high-parameter flow cytometry and live-cell imaging to study killing kinetics, serial killing and repeated mRNA delivery. Phenotypic, transcriptional and epigenetic analyses will identify mechanisms limiting cytotoxicity and routes to improve receptor availability and function. This full-time postdoctoral appointment is based in Flemingsberg; applications through Varbi close on 6 October 2026.

Two faculty appointments in the Laboratory of Phytopathology will develop new approaches to plant–pathogen interactions, disease resilience and pathogen adaptation. Relevant directions include theoretical phytopathology, predictive modelling, quantitative immunity and structural biology. The roles combine research funding, teaching, supervision, collaboration and staff mentoring within the university’s Professor Career Paths framework. Apply online by 10 October inclusive; applications are reviewed regularly and posts may fill earlier.

Support animal-virus diagnostics and vaccine research within the One Health Virology team at Wageningen Bioveterinary Research. Work includes developing and validating PCR, sequencing and immunological assays, characterising outbreak viruses and maintaining research data. Based in Lelystad for 32–36 hours weekly, initially on a one-year contract with possible renewal. Apply through the university website by 12 October inclusive.

Flexible support of up to USD 25,000 for postdoctoral autism researchers affected by lost, reduced or suspended funding. Basic and clinical autism research is eligible, including neurobiology, genetics, immunology, model systems, behaviour and service research, with priority for profound autism. Awards cover specific research and career-development expenses, including supplies, data access, participant costs and limited travel or training. They do not replace the fellow’s salary or stipend. Applications and a separate recommender letter are due 15 October 2026 at 5 p.m. Eastern Time. Awards are announced in March 2027 and must start between June and September 2027. The official RFA instructs applicants and recommenders to submit their PDFs by email.

Marcus Buggert’s group at the Centre for Infectious Medicine develops mRNA-based, CD19-directed CAR T cells for chronic lymphocytic leukaemia. The project uses electroporation and targeted lipid nanoparticles to generate transient CAR expression and examines how disease stage, treatment and T-cell differentiation affect killing of malignant B cells. Work combines primary human cells and patient samples, functional co-cultures, high-parameter flow cytometry and live-cell imaging to study killing kinetics, serial killing and repeated mRNA delivery. Phenotypic, transcriptional and epigenetic analyses will identify mechanisms limiting cytotoxicity and routes to improve receptor availability and function. This full-time postdoctoral appointment is based in Flemingsberg; applications through Varbi close on 6 October 2026.

This meeting examines how pollutants, infections and other environmental exposures interact with genetic susceptibility to cause chronic inflammatory disease. Immunologists and environmental scientists study how barrier-surface immunity decodes these influences. The programme combines early-life and population cohorts, single-cell methods, microbial and dietary environments, experimental exposures and mucosal defence to connect mechanisms with prevention and treatment. Programme participants include Martine Vrijheid (Barcelona Institute for Global Health, Spain); Petter Brodin (Imperial College London, UK); Darragh Duffy (Pasteur Institute, France); Magnus Rattray (University of Manchester, UK); Sheena Cruickshank (University of Manchester, UK); Fenna Sillé (Johns Hopkins University, US). Schedule: 12–13 October 2026, 09:00–17:00 each day, Europe/London (BST, UTC+1). Researchers may attend online or at the Royal Society, 6–9 Carlton House Terrace, London SW1Y 5AG, United Kingdom. Both modes are free; advance registration is required using the appropriate online or in-person ticket. Optional lunch is £25/day, subject to availability; outside food is permitted. A poster session is planned for 12 October; no fixed submission deadline is stated.

Study how T cells and natural killer cells sense and respond to mechanical forces. Develop and apply molecular tools, protein and antibody engineering, and biophysical measurements to investigate immune-cell activation and opportunities for immunotherapy. The full-time role is based in Rong Ma’s research environment. Apply through Varbi by 16 October 2026.